We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Offers More Industry Feedback in New Drug Review Proposal
FDA Offers More Industry Feedback in New Drug Review Proposal
December 7, 2010
The FDA has proposed adding a late-stage meeting with sponsors to the review process for new drugs and biologics in an effort to address drugmakers’ calls for increased feedback from the agency.